Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

XXII vs CGC

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
XXII
22nd Century Group, Inc.

Tobacco

Consumer DefensiveNASDAQ • US
Market Cap$119K
5Y Perf.-100.0%
CGC
Canopy Growth Corporation

Drug Manufacturers - Specialty & Generic

HealthcareNASDAQ • CA
Market Cap$122M
5Y Perf.-99.3%

XXII vs CGC — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
XXII logoXXII
CGC logoCGC
IndustryTobaccoDrug Manufacturers - Specialty & Generic
Market Cap$119K$122M
Revenue (TTM)$19M$294M
Net Income (TTM)$-4M$-327M
Gross Margin-15.2%22.8%
Operating Margin-62.0%-24.1%
Total Debt$4M$348M
Cash & Equiv.$7M$114M

XXII vs CGCLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

XXII
CGC
StockMay 20May 26Return
22nd Century Group,… (XXII)1000.0-100.0%
Canopy Growth Corpo… (CGC)1000.7-99.3%

Price return only. Dividends and distributions are not included.

Quick Verdict: XXII vs CGC

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: XXII leads in 5 of 6 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. Canopy Growth Corporation is the stronger pick specifically for recent price momentum and sentiment. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
XXII
22nd Century Group, Inc.
The Income Pick

XXII carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.

  • Dividend streak 0 yrs, beta 1.60, yield 100.0%
  • Rev growth 48.1%, EPS growth 99.9%, 3Y rev CAGR -24.3%
  • Lower volatility, beta 1.60, Low D/E 26.7%, current ratio 2.42x
Best for: income & stability and growth exposure
CGC
Canopy Growth Corporation
The Long-Run Compounder

CGC is the clearest fit if your priority is long-term compounding.

  • -94.3% 10Y total return vs XXII's -100.0%
  • -12.4% vs XXII's -99.8%
Best for: long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthXXII logoXXII48.1% revenue growth vs CGC's -9.5%
Quality / MarginsXXII logoXXII-20.5% margin vs CGC's -111.0%
Stability / SafetyXXII logoXXIIBeta 1.60 vs CGC's 1.90, lower leverage
DividendsXXII logoXXII100.0% yield; the other pay no meaningful dividend
Momentum (1Y)CGC logoCGC-12.4% vs XXII's -99.8%
Efficiency (ROA)XXII logoXXII-14.2% ROA vs CGC's -29.5%, ROIC -81.4% vs -10.2%

XXII vs CGC — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

XXII22nd Century Group, Inc.
FY 2025
Contract Manufacturing
50.0%$17M
Cigarettes
37.0%$13M
Filtered Cigars
11.8%$4M
Other Tobacco Products
1.3%$442,000
CGCCanopy Growth Corporation
FY 2024
Canadian Cannabis Net Revenue
57.9%$156M
Storz And Bickel
27.3%$73M
International And Other Revenue
14.8%$40M
Other Revenue
0.0%$0

XXII vs CGC — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLXXIILAGGINGCGC

Income & Cash Flow (Last 12 Months)

CGC leads this category, winning 4 of 6 comparable metrics.

CGC is the larger business by revenue, generating $294M annually — 15.2x XXII's $19M. XXII is the more profitable business, keeping -20.5% of every revenue dollar as net income compared to CGC's -111.0%. On growth, XXII holds the edge at +80.4% YoY revenue growth, suggesting stronger near-term business momentum.

MetricXXII logoXXII22nd Century Grou…CGC logoCGCCanopy Growth Cor…
RevenueTrailing 12 months$19M$294M
EBITDAEarnings before interest/tax-$11M-$32M
Net IncomeAfter-tax profit-$4M-$327M
Free Cash FlowCash after capex-$8M-$86M
Gross MarginGross profit ÷ Revenue-15.2%+22.8%
Operating MarginEBIT ÷ Revenue-62.0%-24.1%
Net MarginNet income ÷ Revenue-20.5%-111.0%
FCF MarginFCF ÷ Revenue-40.8%-29.3%
Rev. Growth (YoY)Latest quarter vs prior year+80.4%+20.9%
EPS Growth (YoY)Latest quarter vs prior year+58.0%+83.8%
CGC leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

XXII leads this category, winning 2 of 3 comparable metrics.
MetricXXII logoXXII22nd Century Grou…CGC logoCGCCanopy Growth Cor…
Market CapShares × price$118,791$122M
Enterprise ValueMkt cap + debt − cash-$3M$293M
Trailing P/EPrice ÷ TTM EPS-0.01x-0.28x
Forward P/EPrice ÷ next-FY EPS est.
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple
Price / SalesMarket cap ÷ Revenue0.01x0.62x
Price / BookPrice ÷ Book value/share0.01x0.34x
Price / FCFMarket cap ÷ FCF
XXII leads this category, winning 2 of 3 comparable metrics.

Profitability & Efficiency

XXII leads this category, winning 5 of 9 comparable metrics.

XXII delivers a -25.0% return on equity — every $100 of shareholder capital generates $-25 in annual profit, vs $-43 for CGC. XXII carries lower financial leverage with a 0.27x debt-to-equity ratio, signaling a more conservative balance sheet compared to CGC's 0.72x. On the Piotroski fundamental quality scale (0–9), CGC scores 5/9 vs XXII's 4/9, reflecting solid financial health.

MetricXXII logoXXII22nd Century Grou…CGC logoCGCCanopy Growth Cor…
ROE (TTM)Return on equity-25.0%-43.1%
ROA (TTM)Return on assets-14.2%-29.5%
ROICReturn on invested capital-81.4%-10.2%
ROCEReturn on capital employed-72.6%-12.4%
Piotroski ScoreFundamental quality 0–945
Debt / EquityFinancial leverage0.27x0.72x
Net DebtTotal debt minus cash-$3M$235M
Cash & Equiv.Liquid assets$7M$114M
Total DebtShort + long-term debt$4M$348M
Interest CoverageEBIT ÷ Interest expense-10.14x-7.79x
XXII leads this category, winning 5 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

CGC leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in CGC five years ago would be worth $45 today (with dividends reinvested), compared to $0 for XXII. Over the past 12 months, CGC leads with a -12.4% total return vs XXII's -99.8%. The 3-year compound annual growth rate (CAGR) favors CGC at -55.9% vs XXII's -99.0% — a key indicator of consistent wealth creation.

MetricXXII logoXXII22nd Century Grou…CGC logoCGCCanopy Growth Cor…
YTD ReturnYear-to-date-94.6%-5.0%
1-Year ReturnPast 12 months-99.8%-12.4%
3-Year ReturnCumulative with dividends-100.0%-91.4%
5-Year ReturnCumulative with dividends-100.0%-99.6%
10-Year ReturnCumulative with dividends-100.0%-94.3%
CAGR (3Y)Annualised 3-year return-99.0%-55.9%
CGC leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

Evenly matched — XXII and CGC each lead in 1 of 2 comparable metrics.

XXII is the less volatile stock with a 1.60 beta — it tends to amplify market swings less than CGC's 1.90 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CGC currently trades 47.5% from its 52-week high vs XXII's 0.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricXXII logoXXII22nd Century Grou…CGC logoCGCCanopy Growth Cor…
Beta (5Y)Sensitivity to S&P 5001.60x1.90x
52-Week HighHighest price in past year$455.40$2.38
52-Week LowLowest price in past year$0.67$0.84
% of 52W HighCurrent price vs 52-week peak+0.2%+47.5%
RSI (14)Momentum oscillator 0–10015.152.9
Avg Volume (50D)Average daily shares traded1.4M10.4M
Evenly matched — XXII and CGC each lead in 1 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

XXII is the only dividend payer here at 100.00% yield — a key consideration for income-focused portfolios.

MetricXXII logoXXII22nd Century Grou…CGC logoCGCCanopy Growth Cor…
Analyst RatingConsensus buy/hold/sellHold
Price TargetConsensus 12-month target$14.47
# AnalystsCovering analysts26
Dividend YieldAnnual dividend ÷ price+100.0%
Dividend StreakConsecutive years of raises0
Dividend / ShareAnnual DPS$25.42
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%
Insufficient data to determine a leader in this category.
Key Takeaway

CGC leads in 2 of 6 categories (Income & Cash Flow, Total Returns). XXII leads in 2 (Valuation Metrics, Profitability & Efficiency). 1 tied.

Best Overall22nd Century Group, Inc. (XXII)Leads 2 of 6 categories
Loading custom metrics...

XXII vs CGC: Frequently Asked Questions

8 questions · data-driven answers · updated daily

01

Is XXII or CGC a better buy right now?

For growth investors, 22nd Century Group, Inc.

(XXII) is the stronger pick with 48. 1% revenue growth year-over-year, versus -9. 5% for Canopy Growth Corporation (CGC). Analysts rate Canopy Growth Corporation (CGC) a "Hold" — based on 26 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which is the better long-term investment — XXII or CGC?

Over the past 5 years, Canopy Growth Corporation (CGC) delivered a total return of -99.

6%, compared to -100. 0% for 22nd Century Group, Inc. (XXII). Over 10 years, the gap is even starker: CGC returned -94. 3% versus XXII's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

03

Which is safer — XXII or CGC?

By beta (market sensitivity over 5 years), 22nd Century Group, Inc.

(XXII) is the lower-risk stock at 1. 60β versus Canopy Growth Corporation's 1. 90β — meaning CGC is approximately 18% more volatile than XXII relative to the S&P 500. On balance sheet safety, 22nd Century Group, Inc. (XXII) carries a lower debt/equity ratio of 27% versus 72% for Canopy Growth Corporation — giving it more financial flexibility in a downturn.

04

Which is growing faster — XXII or CGC?

By revenue growth (latest reported year), 22nd Century Group, Inc.

(XXII) is pulling ahead at 48. 1% versus -9. 5% for Canopy Growth Corporation (CGC). On earnings-per-share growth, the picture is similar: 22nd Century Group, Inc. grew EPS 99. 9% year-over-year, compared to 37. 1% for Canopy Growth Corporation. Over a 3-year CAGR, CGC leads at -17. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

05

Which has better profit margins — XXII or CGC?

22nd Century Group, Inc.

(XXII) is the more profitable company, earning -28. 7% net margin versus -222. 4% for Canopy Growth Corporation — meaning it keeps -28. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CGC leads at -43. 5% versus -64. 9% for XXII. At the gross margin level — before operating expenses — CGC leads at 29. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

06

Which pays a better dividend — XXII or CGC?

In this comparison, XXII (100.

0% yield) pays a dividend. CGC does not pay a meaningful dividend and should not be held primarily for income.

07

Is XXII or CGC better for a retirement portfolio?

For long-horizon retirement investors, 22nd Century Group, Inc.

(XXII) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (100. 0% yield). Canopy Growth Corporation (CGC) carries a higher beta of 1. 90 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (XXII: -100. 0%, CGC: -94. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

08

What are the main differences between XXII and CGC?

These companies operate in different sectors (XXII (Consumer Defensive) and CGC (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: XXII is a small-cap high-growth stock; CGC is a small-cap quality compounder stock. XXII pays a dividend while CGC does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

XXII

High-Growth Disruptor

  • Sector: Consumer Defensive
  • Market Cap > $20B
  • Revenue Growth > 40%
  • Dividend Yield > 40.0%
Run This Screen
Stocks Like

CGC

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 10%
  • Gross Margin > 13%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform XXII and CGC on the metrics below

Revenue Growth>
%
(XXII: 80.4% · CGC: 20.9%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.